Skip to main content
Premium Trial:

Request an Annual Quote

John Niederhuber, Judy Garber, Geoffrey Ginsburg, Giovanni Parmigiani, David Rimm, Howard Scher

Konica Minolta Precision Medicine has announced the formation of its scientific advisory board, which include John Niederhuber, Judy Garber, Geoffrey Ginsburg, Giovanni Parmigiani, David Rimm, and Howard Scher. John Niederhuber has also been appointed as the board's chairman.

Niederhuber is currently CEO of the Genomics and Bioinformatics Research Institute, and formerly served as the director of the National Cancer Institute  and the National Institutes of Health.

Garber is currently chief of the division of cancer genetics and prevention at the Dana-Farber Cancer Institute, as well as a professor at Harvard Medical School.

Ginsburg currently serves as the founding director at the center for applied genomics & precision medicine at the Duke University Medical Center.

Parmigiani is currently associate director for population sciences of the multi-institutional Dana-Farber/Harvard Cancer Center, as well as director of the postdoctoral training grant in quantitative sciences for Cancer research at the Harvard T.H. Chan School of Public Health.

Rimm currently serves as professor of pathology and medicine at the Yale University School of Medicine, as well as the director of Yale Pathology Tissue Services.

Scher acts as the co-chair for mechanism based therapy and head of the biomarker development initiative at Memorial Sloan Kettering Cancer Center.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.